-
FRAILTY AND INFLAMMATION AS PREDICTORS OF MORTALITY IN PATIENTS UNDERGOING ELECTIVE CARDIAC SURGERY
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF TARDIVE DYSKINESIA AMONG HOSPITALIZED SCHIZOPHRENIA PATIENTS: EVIDENCE FROM US ADMINISTRATIVE DATA
Mar 18, 2026, 21:38 PM -
WHICH PROVIDERS PRESCRIBE ANTIVIRALS FOR COVID-19 TREATMENT IN THE US?
Mar 18, 2026, 21:38 PM -
COST OF ILLNESS AMONG ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) MEDICARE PATIENTS IN THE UNITED STATES BETWEEN 2011-2021
Mar 18, 2026, 21:38 PM -
ASSESSING THE RETURN ON INVESTMENT (ROI) OF HEOR & RWE TO THE BIOPHARMACEUTICAL INDUSTRY: CASE EXAMPLE OF ECONOMIC MODELING IN HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS
Mar 18, 2026, 21:38 PM -
A MULTI-AGENT GENAI SYSTEM FOR TRACEABLE, MULTI-COUNTRY LANDSCAPE ASSESSMENT IN MASH
Mar 18, 2026, 21:38 PM -
FROM REAL-WORLD DATA (RWD) TO DIGITAL TWINS: BUILDING MODELS FOR PATIENT-LEVEL COUNTERFACTUAL PREDICTION IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
AFFORDABILITY OF NOVEL DISEASE-MODIFYING THERAPIES: TAFAMIDIS AND ATTR-CM
Mar 18, 2026, 21:38 PM -
EVALUATING THE IMPACT OF PHARMACIST-LED DIGITAL AND EDUCATIONAL HEALTH INTERVENTIONS FOR DISEASE AND RISK MANAGEMENT ON ISCHEMIC HEART DISEASE PATIENT
Mar 18, 2026, 21:38 PM -
REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) CAPTURES A 2025 STANDARD-OF-CARE (SOC) SHIFT DRIVEN BY ANTIBODY-DRUG CONJUGATES (ADCS) IN UROTHELIAL CARCINOMA (UC): IMPLICATIONS FOR HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF HORMONAL TREATMENT STRATEGIES FOR INFANTILE EPILEPTIC SPASMS SYNDROME IN INDIAN CHILDREN
Mar 18, 2026, 21:38 PM -
OBSERVED CARDIOVASCULAR DISEASE PREVALENCE AMONG OBESE AND TYPE 2 DIABETES PATIENTS WITH AND WITHOUT GLP-1 TREATMENT
Mar 18, 2026, 21:38 PM -
REVIEW OF CEESP ICERS FOR ORPHAN AND NON-ORPHAN TREATMENTS IN FRANCE, 2024 - 2025
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
PRODUCTIVITY IMPACT OF CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES IN U.S. PEDIATRIC AND ADULT POPULATIONS: A MODELING STUDY
Mar 18, 2026, 21:38 PM -
POWER, POLITICS, AND PRICE: GOVERNANCE FAILURES IN NEPAL’S PHARMACEUTICAL SYSTEM AND THE UHC CHALLENGE
Mar 18, 2026, 21:38 PM -
REGULATORY CHALLENGES AND INSIGHTS FROM FDA IN 2025; POTENTIAL IMPLICATIONS OF THE PLAUSIBLE MECHANISM PATHWAY AND SUBSEQUENT HEALTH TECHNOLOGY ASSESSMENTS
Mar 18, 2026, 21:38 PM -
A LONG-TERM COST-EFFECTIVENESS MODELLING STUDY OF SEMAGLUTIDE FOR THE TREATMENT OF ADULTS WITH OVERWEIGHT AND OBESITY IN CHINA
Mar 18, 2026, 21:38 PM -
ENHANCING CLINICAL TRIAL RECRUITMENT THROUGH INTEGRATED PROVIDER AFFILIATION AND REAL-WORLD DATA-DRIVEN HCP TARGETING
Mar 18, 2026, 21:38 PM -
AN INDIRECT TREATMENT COMPARISON (ITC) OF IFINATAMAB DERUXTECAN (I-DXD) VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY (RWPCT) IN PATIENTS PREVIOUSLY TREATED WITH AT LEAST 2 LINES OF THERAPY (LOTS) FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER...
Mar 18, 2026, 21:38 PM
